Form 483

SCA Pharmaceuticals, LLC Form 483, 2019-11-19

FDA issued a Form 483 to SCA Pharmaceuticals, LLC on 2019-11-19 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

SCA Pharmaceuticals, LLC · Windsor, United States · Issued November 19, 2019

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Nov 2019
21 CFR 211.165(b)

Microbiological testing

Cited by Robert J Martin

19 Nov 2019
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Robert J Martin

Inspected site

SPSCA Pharmaceuticals, LLCWindsor, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.165(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere